Objectives: To evaluate the diagnostic criteria for PXE based on molecular data.
Methods: Of 10 families with a positive history of PXE 142 subjects were investigated for clinical symptoms, histological findings and genetic haplotype analysis.
Results: Of these, 25 subjects were haplotypic homozygous for PXE and 23 had typical clinical and histopathological manifestations. Two of the 25 patients showed such marked solar elastosis and macular degeneration that PXE could not be confirmed clinically.
Sixty-seven subject were haplotypic heterozygous carriers and 50 haplotypic homozygous unaffected. Of these 117 subjects, 116 showed no cutaneous or ophthalmologic signs of PXE. In one of the 50 haplotypic homozygous unaffected patients important solar elastosis and scaring of the retina mimicked PXE lesions. Only four of the 67 haplotypic heterozygous carriers had biopsies of nonlesional skin; ail were histopathologically normal.
Conclusions: In our patients, PXE presents as an autosomal recessive genodermatosis.
Correlation of haplotype and phenotype confirmed actual major diagnostic criteria. In patients with marked solar elastosis and/ or severe macular degeneration clinical diagnosis can be impossible and molecular testing is needed to confirm the presence of PXE. To the best of our knowledge our large study compares for the first time clinical findings with molecular data. 
'
8 This gene encodes a transmembrane transporter protein which belongs to the same family of proteins as those defective in cystic fibrosis or Tangier disease. ABC-C6 is expressed primarily in the liver and the kidney, 9 suggesting that transporter dysfunction may lead to accumulation of an unknown substrate in the blood causing secondary dystrophie changes of elastic tissues.
10
Skin lesions consist of yellowish papules or plaques with loss of dermal elasticity.11'
12
Commonly affected sites are the flexures and periumbilical skin. 10 Mucous membrane involvement is not rare. 13 Skin lesions are usually noted in the second or third decade.
10
Histology of skin lesions shows calcification, alteration and fragmentation of elastic structures in the mid dermis. To facilitate and unify the clinical diagnosis for PXE, three major diagnostic criteria (characteristic skin involvement, characteristic histopathological features of lesional skin, characteristic ocular disease) and two minor criteria ( characteristic dermatopathological features in nonlesional skin, family history of PXE in first-degree relatives) were defined and divided in five categories (1, Ila-d) at the consensuses conference in 1992.
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The objectives of this study were to evaluate the diagnostic criteria for PXE in the context of precise molecular data.
PATIENTS AND METHODS
Ali subjects with PXE or a positive family history of PXE were eligible for this study.
Institutional ethic committee approved consent was obtained from ail adults, children when age appropriate or their parents. A detailed family and medical history was noted.
Ali volunteers were subject to clinical examination. Dermatological and ophthalmological findings were photo-documented. Accurate pedigree data comprising at least three successive generations were compiled. For DNA extraction, blood samples were taken from every subject older then 16 years of age; otherwise buccal cells were collected.
High molecular weight genomic DNA was extracted from 1ml ethylenediamine tetraacetic acid-anticoagulated whole blood using a commercially available, adsorption-based method (QlAmp, Qiagen, Valencia, CA, U.S.A), and stored at -80°C. The buccal cells
were collected according to the protocol of Richards et al. 19 and the DNA was stored at 4°C. Sequence and genotype analysis were done as previously reported. 2 To correlate the extent of clinical alterations, the histopathological findings and the molecular genetic data, cutaneous and histological findings were graded in all subjects.
Cutaneous clinical alterations were graded 1+ if unequivocal but sparse yellow papules had been noted in one or more body folds; 2+ if numerous typical, confluent yellow xanthoma-like lesions had been observed; and 3+ if, in addition to these changes, the skin was lax and redundant. Mucosal lesions were considered but not graded.
In 23 adult subjects with typical cutaneous PXE, in four obligate heterozygotes without skin lesions and in three subjects with marked solar elastosis, two 5-mm skin punchbiopsy were taken, under local anaesthesia, from a predilection site, usually in the neck or antecubital fossa. No biopsies were performed in children as they did not show any skin lesions clinically. Biopsies of unaffected skin from four volunteers who did not belong to one of the 10 families of the present study were used as control material. Specimens for light microscopy were fixed in neutral buffered formalin, dehydrated, embedded in paraffin, serially sectioned and stained with haematoxylin-eosin, elastin stain for elastic tissue and Von Kossa stain for calcium phosphates. Stained sections were code-labelled and examined independently by three observers without knowledge of the patient's name 7 or diagnosis. The changes consistent with PXE were graded 1+ if small, patchy areas of swollen, fragmented and irregularly clumped elastic fibres were seen in the mid dermis of sections stained by haematoxylin and eosin and elastin stains and if small amounts of calcium were seen in the same areas in serial sections stained by Von Kossa method. A 3+ score was given if all the elastic fibres in a wide band throughout the mid and lower dermis were affected. Sections were judged to display 2+ changes if the extent of elastic fibres alterations lay between these two extremes. years, presented the three major diagnostic criteria of PXE. In three more subjects a marked solar elastosis and severe macular degeneration made it impossible to exclude PXE clinically. These three patients, two females and one male, ages 73-79 years belong to the same family. They are all farmers with important sun exposure and suffer from 'Zermatt macular dystrophy', a dominant, age-related, progressive macular dystrophy.
In view of the variable expression and possible late onset of the disease ail 142 individuals were included in the genetic analysis. This resulted in the identification of 25 haplotypic h'omozygous affected individuals, 67 haplotypic heterozygous carriers and 50 haplotypic homozygous unaffected members ( Table 1) . The pedigree showed a high level of consanguinity and a strictly horizontal pattern of disease prevalence (Fig.1) .
In 23 patients, homozygous for PXE, we observed the typical appearance ( Fig.2) and distribution of skin lesions. The skin alterations ranged from a few yellow papules to confluent plaques causing redundant folds. They were regarded as slight in three patients, moderate in 14, and severe in six ( Table 2 ). Eleven of the 23 patients showed typical cobblestone-like changes on the buccal mucosa (Fig.3) . The age at onset of the skin lesions varied from 12 to 38 years of age in 17 patients. In six patients the skin lesions had never been noted before the study. The skin lesions were first noticed at a mean age of 17 years but a precise diagnose was made only at a mean age of 40 years (Table 3) . Ali 67 subjects, heterozygous for PXE, and 49 of the 50 noncarriers showed no cutaneous or mucosal lesions of PXE.
Independent interpretations of three histological observers regarding presence or absence of PXE were identical for 31 of 34 biopsy sections. The 23 cases, homozygous for PXE, showed the characteristic histological alterations. They were regarded as slight in three patients, moderate in 16, and severe in four. The correlation between the severity of clinical change and of histology was excellent (Table 2 ). In four heterozygous carriers for PXE and four volunteers the skin biopsy of nonlesional skin showed no histological alterations. In three patients (two homozygous for PXE and one noncarrier) with marked solar elastosis and severe macular degeneration, the clinical and histological interpretation was not clear. Haematoxylin and eosin-stained sections were usually adequate for detection of PXE. Von Kossa staining for calcium was of additional value in confirming subtle lesions, while elastic tissue staining was least useful.
Ali 23 of homozygous patients for PXE had angioid streaks and peau d'orange pigmentation in both eyes (Fig.4) . Eight of the 23 had subretinal neomembranous complications at the posterior pole leading to visual impairment. The fundus lesions were diagnosed at a mean age of 47.8 years and initial ophthalmic complications presented in middle age (Table 3 ). In the three patients (two homozygous for PXE and one noncarrier) whose clinical and histological interpretation was not clear for PXE, important scarring of the retina made the diagnosis of angioid steaks or peau d'orange impossible. In our series, the ophthalmologic manifestations were responsible for more morbidity than the involvement of any other organ system.
The most common findings of cardiovascular manifestation in the 23 confirmed cases of PXE were hypertension (> 140/90) in 11 patients (48%) at a mean age of 62.2 years, heart murmurs in 10 (43%) at a mean age of 49.6, coronary artery disease (CAO) in eight (35%) at a mean age of 59.4, abnormal pedal pulses in three (13%) at a mean age of 66.7, intermittent claudication in three (13%) at a mean age of 53.7 and strokes in three (13%) at a mean age of patients 72.7 years. These patients showed no other risk factor for cardiovascular diseases such as diabetes, tobacco abuse or high blood cholesterol levels.
DISCUSSION
In this paper we exploit molecular genetic haplotype analysis to review the validity of clinical and histological criteria to diagnose PXE. The 10 examined families corne from isolates of the Swiss Valais canton, a reg ion of genetic nondisperation, offering a unique source for genetic analysis. In this specific region the PXE incidence is approximately 1 in 10'000 and the heterozygote frequency is 1 in 50. 19 In general estimates, the prevalence PXE ranges from 1 in 70'000 to 1 in 1 million
•
In our study we found 67 haplotypic heterozygous carriers, 50 haplotypic homozygous unaffected family members and 25 haplotypic homozygous affected individuals. They ail showed autosomal recessive inheritance. According to the diagnostic criteria for PXE defined at the consensuses conference held in 1992, 18 we classified 23 of 25 homozygous PXE carriers, clinically as category I (three major criteria). We did not find ocular disease compatible with PXE in any of our haplotypic heterozygous carriers. This allowed us to exclude the presence of clinical type Ila (angioid streaks and two miner criteria), Ilb and Ile (angioid streaks and one miner criterion) PXE in our study. Category Ild (two miner criteria) PXE was excluded in four of 67 heterozygous carriers, as only four had biopsies of nonlesional skin. Further histological examinations of nonlesional skin would be needed to prove the absence of this category.
We observed that the phenotypic manifestations of PXE can show considerable variability within families. There was no correlation seen between the severity of skin, eye or cardiovascular lesions within the same patient. The genetic patterns studied correlated with the presence or absence of disease but could not explain the different degrees of clinical involvement observed. This may indicate that disease expression is possibly influenced by environmental factors.
The average time between the onset of skin lesions and the diagnosis was 23 years. This prolonged time lapse can be explained by the fact that the majority of patients were not concerned by their skin lesions and did not seek medical advice until their initial ophthalmic lesions presented in middle age (average, 48 years).
The histopathology of the skin is an important tool to determine the difference between PXE and skin lesions that superficially resemble PXE, such as solar elastosis, cutis laxa,
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penicillamine therapy, lesions secondary to vitamin D toxicity or renal disease.
It is important to keep in mind that isolated angioid streaks without any other features do not allow a formai diagnosis of PXE. They are observed in many other diseases 22 and
should be regarded as a sign of a possible generalized disorder.
Cardiovascular features in PXE are well described.
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In the assessment of other organ systems it was surprising that gastrointestinal haemorrhage was not a major problem in our patients, although frequently reported in literature. 24 We observed a higher incidence of hypertension in patients with PXE than in the mean population. This could be explained by slowly progressive calcification of the elastic arterial wall 17 with graduai reduction of vessel lumen.
The clinical diagnosis of PXE can be a challenge in the presence of age changes such as solar elastosis or in the late stages of macular degeneration where the angioid streaks may be obscured. Three of our subjects showed such a marked solar elastosis and an important scarring of the retina that we were notable to make the diagnosis of PXE clinically. In this situation a reliable molecular test is helpful. The genetic analysis showed that two of the three had PXE. Diagnosis of the disease is important, although there is no treatment for the basic defect. A prophylactic lifestyle, prophylactic medical monitoring, and genetic counselling are highly recommended.
This report shows an excellent correlation between haplotype and typical clinical manifestation (cutaneous signs, histology of lesional skin and ocular involvement) in PXE.
It confirms the validity of the three major clinical diagnostic criteria for category I PXE.
One of the two minor criteria, which was a positive family history of PXE, was an important element of diagnose in our study. The other minor diagnostic criteria, which consists of characteristic dermatopathological features in nonlesional skin, was not of any major help in the diagnosis of our patients. Besides, in patients with a positive family history of PXE but without cutaneous or ocular manifestations, it can be difficult to justify a skin biopsy. Table 1 Summary of results   Table 2 Grading of skin lesions and histological features in 23 of 25 homozygous affected individuals. Table 3 Mean age at clinical manifestation of pseudoxanthoma elasticum. (solid square or circle), dead (/), study subjects (arrow), adopted (diamond with square). 
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